You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Conjugation
Biologically Active
Featured Product
Search results for: 'active'
RecombinantFGF-16,Human [orb1494749]> 95% as analyzed by SDS-PAGE and HPLC.
23 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg> 98% as analyzed by SDS-PAGE.
8.3 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg> 98% as analyzed by SDS-PAGE.
8.7 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg, 1 mg> 95% as analyzed by SDS-PAGE and HPLC.
42 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg> 98% as analyzed by SDS-PAGE.
70-90 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg- RecombinantFasR,Human [orb1494650]
> 95% as analyzed by SDS-PAGE.
17~29 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg - RecombinantCT‑1,Mouse [orb1494652]
> 95% as analyzed by SDS-PAGE.
22~27 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg - RecombinantVEGF-D,Human [orb1494659]
> 95% as analyzed by SDS-PAGE and HPLC.
18-19 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg - RecombinantTPO,His,Rat [orb1494663]
> 98% as analyzed by SDS-PAGE.
22 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg > 97% as analyzed by SDS-PAGE and HPLC.
9.8 kDa, observed by reducing SDS-PAGE.
CHO
25 μg, 5 μg, 1 mg